-transparent.png){kind=logo}
Sisomicin, at 4.5 mg/kg per day, was prescribed for the therapy of serious bacterial infections of hospitalized infants, children, and adolescents. Eleven children received full treatment courses, with 10 clinical and 9 bacteriological cures. Three patients with underlying disease (two cystic fibrosis and one aplastic anemia) accounted for the failures. Mean half-life was 98.3 min (range, 26.1 to 159.3), and peak serum concentrations 10 min after intravenous infusion were similar (5 to 6 mug/ml) on days 1, 3, and 5 of therapy. Mean urinary concentrations were 54.3 mug/ml; 31 to 47% of the drug was excreted within the 8-h dosage interval. The drug was tolerated well by all patients; however, one patient, receiving the longest duration of therapy (26 days), developed reversible nephrotoxicity.
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
July 1973,
Deutsche medizinische Wochenschrift (1946),
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
October 1971,
Orvosi hetilap,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
August 1976,
Current therapeutic research, clinical and experimental,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
January 1984,
Veterinarno-meditsinski nauki,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
December 1988,
Thrombosis research,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
June 1973,
Casopis lekaru ceskych,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
March 1980,
The Japanese journal of antibiotics,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
January 1968,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
October 1968,
Munchener medizinische Wochenschrift (1950),
M I Marks, and
A Vose, and
S Hammerberg, and
R Dugal
September 1975,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
